Crescent Biopharma, Inc. CBIO
12.94 USD -0.88 (-6.37%)
At closeNov 5, 2026, 4:01 PM EST
12.94 0.00 0.00%
After hours · Nov 5, 4:01 PM ET
12.72 Day range 13.77
8.72 52-week range 27.41
- YTD
- +9.11%
- 1 year
- +4.10%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 10.84M | 0 | 10.00K | 75.00K | 1.16M | |
| 10.84M | 0 | 10.00K | 75.00K | 1.16M | |
| -152.63M | -40.04M | -39.28M | -47.40M | -63.45M | |
| -153.94M | -37.88M | -36.90M | -46.69M | -63.43M | |
| -12.81 | -59.00 | -58.00 | -89.00 | -123.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 213.30M | 34.77M | 41.79M | 47.87M | 90.31M | |
| 240.29M | 35.62M | 45.32M | 51.81M | 94.35M | |
| 37.28M | 47.10M | 6.90M | 8.88M | 12.74M | |
| 1.64M | 37.48M | 808.40K | 918.55K | 1.92M | |
| 203.01M | -15.48M | 38.41M | 42.93M | 81.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -71.53M | -31.10M | -34.88M | -46.46M | -57.49M | |
| -72.92M | 20.03K | -21.39K | -84.19K | -14.94K | |
| 322.98M | 5.40K | 28.82M | 4.16M | 10.72M | |
| -919.00K | 20.03K | -21.39K | -84.19K | -14.94K | |
| 178.53M | -31.07M | -6.08M | -42.38M | -46.78M |